The activation of pancreatic stellate cells (PSCs) was found to promote the progression of Pancreatic ductal adenocarcinoma (PDAC) via metabolic crosstalk. Here, this group designs a liposome nanosystem encapsulating NF-κB inhibitor (TPCA-1) and CD71 aptamerlinked glucose transporter 1 (GLUT1) siRNA to dual rectify the metabolism abnormalities of PDAC cells and reverses the activated PSC to quiescence.
- Bowen Wu
- Zhiqin Wang
- Guangjun Nie
